In the above-mentioned article, the authors want to update the errors in Results and Table 3, specifically the errors in the percentages and the subheadings with clearer meaning. The authors regret this error and would like to apologize for any inconvenience caused.
In the result section, “Of 63 cases, 96.8% were reported to have comorbidities: 47.6% hypertension, 36.5% diabetes, 16% neurodegenerative disorders, and 17.5% pulmonary diseases.” should be changed to: “Of 66 cases, 92.4% were reported to have comorbidities: 45.4% hypertension, 34.8% diabetes, 24.2% neurodegenerative disorders, and 16.7% pulmonary diseases”.
The results related to fatal cases in Table 3 should be changed as follows.
Table 3.
Fatal cases (n = 66) of laboratory-confirmed COVID -19 cases, as of March 12th 2020, Republic of Korea.
| Variables | n | (%) |
|---|---|---|
| Age, years, median (range) | 77 | (35–93) |
|
| ||
| Sex | ||
| Female | 29 | (43.9) |
| Male | 37 | (56.1) |
|
| ||
| Coexisting condition* | ||
| Any | 61 | (92.4) |
| Cerebrovascular disease | 5 | (7.6) |
| Heart disease | 10 | (15.2) |
| Pulmonary disease | 11 | (16.7) |
| Kidney disease | 5 | (7.6) |
| Diabetes | 23 | (34.8) |
| Hypertension | 30 | (45.4) |
| Cancer | 7 | (10.6) |
| Neurodegenerative disorder | 16 | (24.2) |
| Under investigation | 5 | (7.6) |
|
| ||
| Region | ||
| Daegu | 47 | (71.2) |
| Gyeongbuk | 16 | (24.2) |
| Others | 3 | (4.5) |
|
| ||
| Death before admission | 5 | (7.6) |
| Interval, days, median (range) | ||
| Symptom → Death | 10 | (1–24) |
| Symptom → Diagnosis | 4 | (0–20) |
| Symptom → Hospitalization | 4.5 | (0–11) |
| Hospitalization → Death | 5 | (0–16) |
|
| ||
| Total | 66 | |
A single case may have multiple comorbidities (investigation files required).